Physician

Samuel Chakola, M.D.

According to 2025 Medicare claims, Samuel Chakola, M.D. (NPI: 1932485604) practices nephrology in the Casper, WY market, with the plurality of this provider's patient population coming from Natrona, WY. This provider's primary affiliated billing organization is BANNER HEALTH PHYSICIANS WEST LLC (NPI: 1063778728; TIN: 900733283) and primary practice location at 82601-1332.

Chakola's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 512 traditional Medicare patients, billed 1,726 HCPCS/CPT codes, and received $195,937 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,379 prescription claims across 246 beneficiaries totaling $338,840 in drug costs, led by Jardiance (Empagliflozin). DME data shows 964 claims. Open Payments data shows 1 records totaling $80. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $9,437 to $338,840. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	203	504	$43,578
2021	597	2,577	$238,468
2022	582	2,159	$226,487
2023	492	1,567	$192,141
2024	512	1,726	$195,937

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	18	72	$9,437
2016	50	310	$11,674
2017	26	165	$19,293
2018	N/R	11	$479
2019	N/R	N/R	N/R
2020	28	64	$2,872
2021	142	808	$86,670
2022	184	1,179	$231,932
2023	225	1,309	$286,436
2024	246	1,379	$338,840

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	125	$4,872
2022	12	278	$13,787
2023	60	675	$40,900
2024	88	964	$61,244

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	67	236	$289
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	93	166	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	233	406	$92
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	161	356	$62
90935	Hemodialysis procedure with physician evaluation	50	127	$57

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	85	3,627	$70,915
Procrit	Epoetin Alfa	16	564	$14,307
Eliquis	Apixaban	11	450	$8,799
Cinacalcet Hcl	Cinacalcet Hcl	14	941	$5,270
Sevelamer Carbonate	Sevelamer Carbonate	31	1,593	$3,669

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	11	86	$40,865
J7518	Mycophenolic acid, oral, 180 mg	N	16	143	$7,145
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	25	196	$3,613
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	25	278	$3,474
J7515	Cyclosporine, oral, 25 mg	N	N/R	19	$2,960

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$80	Outset Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samuel Chakola, M.D.?

Tedicare shows public-source Medicare data for Samuel Chakola, M.D. (NPI 1932485604), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel Chakola, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Samuel Chakola, M.D.?

Samuel Chakola, M.D. is linked to BANNER HEALTH PHYSICIANS WEST LLC (billing NPI 1063778728) in the available physician profile data.

Does Samuel Chakola, M.D. have Open Payments data?

Samuel Chakola, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.